Involvement of tumor necrosis factor-α in development of hepatic injury in galactosamine-sensitized mice
Open accessThe DOI matches its Crossref record.
Abstract
Intravenous injection of lipopolysaccharide and D-galactosamine, at doses of 0.2 μg/kg and 800 mg/kg, respectively, elicited massive hepatic necrosis within 24 hr in C3H/HeN mice. The plasma L-alanine aminotransferase (ALT, E.C. 2.6.1.2) or L-aspartate aminotransferase (AST, E.C. 2.6.1.1) activities at this point reached more than 2,000 IU/L. However, overt hepatic injury as evaluated by the plasma aminotransferase activities did not develop in mice in which only lipopolysaccharide or only D-galactosamine was injected. No tumor necrosis factor—like activities could be detected in the plasma of galactosamine- and lipopolysaccharide-injected mice as determined by the assay of cytotoxicity to highly tumor necrosis factor—sensitive L-P3 cells through the experimental period of 24 hr. However, passive immunization against mouse tumor necrosis factor—α with polyvalent rabbit anti-mouse tumor necrosis factor—α antiserum, which was able to neutralize the cytotoxic effects of recombinant mouse tumor necrosis factor—α on L-P3 cells, could protect the mice from the development of hepatic injury in a dose-dependent manner. Simultaneous injection of recombinant human tumor necrosis factor—α, instead of lipopolysaccharide, with 800 mg/kg of D-galactosamine in lipopolysaccharide-resistant C3H/HeJ mice sensitized the animals more than one thousand-fold to the development of hepatic injury. The livers appeared to be morphologically similar to those of galactosamine- and lipopolysaccharide-injected C3H/HeN mice. These results suggest that endogenous tumor necrosis factor—α participates in the pathogenesis of lipopolysaccharide-elicited hepatic injury, and that tumor necrosis factor plays a crucial role in the development of liver necrosis in galactosamine-sensitized mice. (HEPATOLOGY 1990;12:1187-1191).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Macrophages and Inflammatory Mediators in Tissue Injury
Laskin, D. L., & Pendino, K. J. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003255 · Cited by 617
Macrophages and Tissue Injury: Agents of Defense or Destruction?
Laskin, D. L., Sunil, V. R., Gardner, C. R., & Laskin, J. D. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105812 · Cited by 604
Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., & Fujiwara, H. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1529 · Cited by 517
Iimuro, Y., Gallucci, R. M., Luster, M. I., Kono, H., & Thurman, R. G. (1997) · Hepatology · doi:10.1002/hep.510260621 · Cited by 497
Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
Masaki, T., Chiba, S., Tatsukawa, H., Yasuda, T., Noguchi, H., Seike, M., & Yoshimatsu, H. (2004) · Hepatology · doi:10.1002/hep.20282 · Cited by 402
The importance of immune dysfunction in determining outcome in acute liver failure
Antoniades, C. G., Berry, P. A., Wendon, J. A., & Vergani, D. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.009 · Cited by 367
Increased plasma interleukin-8 concentrations in alcoholic hepatitis
Hill, D. L. B., Marsano, L. S., & McClain, C. J. (1993) · Hepatology · doi:10.1002/hep.1840180316 · Cited by 304
HMGB1 as a DNA-binding cytokine
Andersson, U., Erlandsson-Harris, H., Yang, H., & Tracey, K. J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.6.1084 · Cited by 302
Macrophages and Inflammatory Mediators in Chemical Toxicity: A Battle of Forces
Laskin, D. L. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900086v · Cited by 287
Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF Variants
Steed, P. M., Tansey, M. G., Zalevsky, J., Zhukovsky, E. A., Desjarlais, J. R., Szymkowski, D. E., Abbott, C., Carmichael, D., Chan, C., Cherry, L., et al. (2003) · Science · doi:10.1126/science.1081297 · Cited by 256
Louis, H., Van Laethem, J.-L., Wu, W., Quertinmont, E., Degraef, C., Van den Berg, K., Demols, A., Goldman, M., Le Moine, O., Geerts, A., et al. (1998) · Hepatology · doi:10.1002/hep.510280621 · Cited by 255
Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice
Louis, H., Le Moine, O., Peny, M., Quertinmont, E., Fokan, D., Goldman, M., & Deviere, J. (1997) · Hepatology · doi:10.1002/hep.510250614 · Cited by 177
Zhang, L., Li, H.-Z., Gong, X., Luo, F.-L., Wang, B., Hu, N., Wang, C.-D., Zhang, Z., & Wan, J.-Y. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.01.008 · Cited by 79
Tan, S. C., Bhattamisra, S. K., Chellappan, D. K., & Candasamy, M. (2021) · Applied Sciences · doi:10.3390/app11188475 · Cited by 72
Wang, W., Wu, L., Li, Q., Zhang, Z., Xu, L., Lin, C., Gao, L., Zhao, K., Liang, F., Zhang, Q., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.162 · Cited by 51
Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice
Wang, Y., Wan, Y., Ye, G., Wang, P., Xue, X., Wu, G., & Ye, B. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.08.017 · Cited by 34
Metadata
- Authors
- Hishinuma, I., Nagakawa, J.-I., Hirota, K., Miyamoto, K., Tsukidate, K., Yamanaka, T., Katayama, K.-I., & Yamatsu, I.
- Venue
- Hepatology
- Published
- 1990-11
- Volume
- 12
- Issue
- 5
- Pages
- 1187-1191
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2098650898
- Cited by
- 154
- References
- 0
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.